Document detail
ID
oai:pubmedcentral.nih.gov:1018...
Topic
Brief CommunicationAuthor
Kang, Yu Ri Huh, Jin-Young Oh, Ji-Yoon Lee, Ji-Hyang Lee, Daegeun Kwon, Hyouk-Soo Kim, Tae-Bum Choi, Jae Chol Cho, You Sook Chung, Kian Fan Park, So-Young Song, Woo-JungLangue
enEditor
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
Category
Allergy, Asthma & Immunology Research
Year
2023
listing date
9/22/2023
Keywords
pros symptoms prospective iqr median significantly visit clinical persistent characteristics non-covid weeks cc cough post-covidAbstract
Cough is one of the most common symptoms of acute coronavirus disease 2019, but cough may persist for weeks or months.
This study aimed to examine the clinical characteristics of patients with post-coronavirus disease (COVID) persistent cough in the Omicron era.
We conducted a pooled analysis comparing 3 different groups: 1) a prospective cohort of post-COVID cough (> 3 weeks; n = 55), 2) a retrospective cohort of post-COVID cough (> 3 weeks; n = 66), and 3) a prospective cohort of non-COVID chronic cough (CC) (> 8 weeks; n = 100).
Cough and health status was assessed using patient-reported outcomes (PROs).
Outcomes, including PROs and systemic symptoms, were longitudinally evaluated in the prospective post-COVID cough registry participants receiving usual care.
A total of 121 patients with post-COVID cough and 100 with non-COVID CC were studied.
Baseline cough-specific PRO scores did not significantly differ between post-COVID cough and non-COVID CC groups.
There were no significant differences in chest imaging abnormality or lung function between groups.
However, the proportions of patients with fractional exhaled nitric oxide (FeNO) ≥ 25 ppb were 44.7% in those with post-COVID cough and 22.7% in those with non-COVID CC, which were significantly different.
In longitudinal assessment of the post-COVID registry (n = 43), cough-specific PROs, such as cough severity or Leicester Cough Questionnaire (LCQ) scores, significantly improved between visits 1 and 2 (visit interval: median 35 [interquartile range, IQR: 23–58] days).
In the LCQ score, 83.3% of the patients showed improvement (change ≥ +1.3), but 7.1% had worsened (≤ −1.3).
The number of systemic symptoms was median 4 (IQR: 2–7) at visit 1 but decreased to median 2 (IQR: 0–4) at visit 2.
In summary, post-COVID persistent cough was similar in overall clinical characteristics to CC.
Current cough guideline-based approaches may be effective in most patients with post-COVID cough.
Measurement of FeNO levels may also be useful for cough management.
Kang, Yu Ri,Huh, Jin-Young,Oh, Ji-Yoon,Lee, Ji-Hyang,Lee, Daegeun,Kwon, Hyouk-Soo,Kim, Tae-Bum,Choi, Jae Chol,Cho, You Sook,Chung, Kian Fan,Park, So-Young,Song, Woo-Jung, 2023, Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Era, The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
Neurological manifestation in COVID-19 disease with neuroimaging studies
neuroimaging neurological covid-19
